Brit J Cancer:睾丸癌主动脉辐射后,糖尿病风险研究

2018-10-18 AlexYang MedSci原创

在儿童癌症幸存者中,虽然糖尿病风险在胰腺辐射接触后风险增加,其余睾丸癌(TC)生存者之间的相关性还没有调查。最近,有研究人员在2998名1年TC生存者中研究了糖尿病风险,他们均在50岁之前进行睾丸切除和/或放射治疗,时间均在1976年和2007年之间。研究人员将该群体的糖尿病发生率与普通人群比例进行了比较,并利用一个案例群体设计评估了治疗特异性糖尿病风险。研究发现,平均的跟踪调查时间为13.4年,

儿童癌症幸存者中,虽然糖尿病风险在胰腺辐射接触后风险增加,其余睾丸癌(TC)生存者之间的相关性还没有调查。最近,有研究人员在2998名1年TC生存者中研究了糖尿病风险,他们均在50岁之前进行睾丸切除和/或放射治疗,时间均在1976年和2007年之间。研究人员将该群体的糖尿病发生率与普通人群比例进行了比较,并利用一个案例群体设计评估了治疗特异性糖尿病风险。

研究发现,平均的跟踪调查时间为13.4年,一共有161名TC生存者被诊断为糖尿病。与普通人群的糖尿病发生率比较,糖尿病风险在该人群中并没有显著增加(标准化发生比例(SIR):0.9;95%置信区间(95% CI):0.7-1.1)。在调整了年龄变量后,与没有进行放射治疗患者相比,主动脉放射治疗与糖尿病风险增加1.66倍相关(95% CI: 1.05-2.62)。另外,规定的辐射剂量中,每增加10Gy,超额风险就增加0.31(95% CI: 0.11-0.51, P=0.003,调整后年龄和BMI);而在受辐射的患者中,辐射剂量每增加10 Gy,超额风险就会增加0.33(95% CI: 0.14 -0.81, P=0.169)。

最后,研究人员指出,在TC幸存者中,与只做外科手术的患者相比,主动脉接受辐射与糖尿病风险的增加是相关的。

原始出处:

Harmke J. Groot, Jourik A. Gietema, Berthe M. P. Aleman et al. Risk of diabetes after para-aortic radiation for testicular cancer. Brit J Cancer. 09 Oct 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2055644, encodeId=bb6c20556446a, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 09 21:42:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349368, encodeId=be361349368ef, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368367, encodeId=344f136836ea6, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415393, encodeId=cf67141539344, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041920, encodeId=00b2104192028, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Oct 19 02:42:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2055644, encodeId=bb6c20556446a, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 09 21:42:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349368, encodeId=be361349368ef, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368367, encodeId=344f136836ea6, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415393, encodeId=cf67141539344, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041920, encodeId=00b2104192028, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Oct 19 02:42:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2018-10-20 jiyangfei
  3. [GetPortalCommentsPageByObjectIdResponse(id=2055644, encodeId=bb6c20556446a, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 09 21:42:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349368, encodeId=be361349368ef, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368367, encodeId=344f136836ea6, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415393, encodeId=cf67141539344, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041920, encodeId=00b2104192028, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Oct 19 02:42:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2018-10-20 zhangph
  4. [GetPortalCommentsPageByObjectIdResponse(id=2055644, encodeId=bb6c20556446a, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 09 21:42:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349368, encodeId=be361349368ef, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368367, encodeId=344f136836ea6, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415393, encodeId=cf67141539344, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041920, encodeId=00b2104192028, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Oct 19 02:42:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2055644, encodeId=bb6c20556446a, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 09 21:42:00 CST 2019, time=2019-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349368, encodeId=be361349368ef, content=<a href='/topic/show?id=838593e35b2' target=_blank style='color:#2F92EE;'>#辐射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93735, encryptionId=838593e35b2, topicName=辐射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368367, encodeId=344f136836ea6, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415393, encodeId=cf67141539344, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Oct 20 14:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041920, encodeId=00b2104192028, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Oct 19 02:42:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2018-10-19 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

J Clin Oncol:哪些因素与睾丸癌幸存者发病累积负担相关?

2018年4月,发表在《J Clin Oncol》的一项由美国、印度、加拿大、英国和挪威科学家进行的多中心研究,考察了睾丸癌幸存者在基于顺铂的标准化疗后的发病累积负担(CBM)及其相关因素。

NCCN临床实践指南:睾丸癌(2018.V2)

2018年2月,美国国家综合癌症网络(NCCN)发布了睾丸癌指南2018年第2版,指南主要内容涉及: 指南更新摘要 检查,初级治疗和病理诊断 单纯精原细胞癌诊断后检查和临床分期 非精原细胞癌诊断后检查和临床分期 复发和二线治疗 精原细胞癌的随访 非精原细胞瘤的随访 单纯睾丸精原细胞癌放射治疗原则 进展期疾病风险分层 生

Acta Oncol:睾丸癌幸存者铂化疗前后听力损失研究

听力损失是睾丸癌幸存者(TCS)铂化合物化疗(CBCT)后长期的副作用结果,但是纵向数据仍旧缺乏。最近,有研究人员在他们的纵向研究中,在CBCT处理的TCS中评估了听力损失和年龄的影响。研究发现,年龄和铂剂量与在2-8kHz频率的听力阈值水平(HTL)的较大改变显著相关。对8kHz频率,每100mg累积铂剂量的增加均与3.6dB的退化相关((95% CI 1.8-5.3, p<0.001)。

CLIN CANCER RES:ACYP2和WFS1药物基因组学改变在睾丸癌患者顺铂诱导的耳毒性中发挥的作用

约五分之一接受顺铂治疗的成人患者会出现药物不良反应,如耳毒性。这会给患者增加巨大的社会经济学负担,尤其是在成人早期发展的睾丸癌患者。近期的基因组相关研究发现ACYP2和WFS1基因改变与顺铂诱导的耳毒性有关。CLIN CANCER RES近期发表了一篇文章,研究睾丸癌患者中这些基因易感因素与顺铂诱导的耳毒性中发挥的作用。 作者收集了229例接受顺铂治疗的睾丸癌患者的临床和人口学数据。患者进行两种

Brit J Cancer:高强度间歇训练对睾丸癌幸存者疲劳和生活质量影响研究

睾丸癌幸存者(TCS)处于癌症相关疲劳、心理障碍和生活质量相关的心理障碍(HRQoL)风险增加的情况中。最近,研究人员调查了高强度的间歇训练(HIIT)在TCS患者中对病人报道的结果(PROs)的影响。之后,研究人员探索了心肺功能作为干预效果的一个调节标记,并挑选了干预效果调节标记的基线特性。研究包括了63名TCS患者,并且随机分配到监督下的HIIT组或者常规护理组中。并在基线点、干预后和跟踪调查

Brit J Cancer:睾丸癌患者主动脉旁放射治疗后患糖尿病的风险如何?

由此可见,与仅接受手术治疗相比,主动脉旁照射与TC幸存者糖尿病风险增加有关。